Form 4 for CRL Charles River Laboratories
Accepted 2022-02-23 00:00:00 ET · period of report 2022-02-08 · accession 0001127602-22-006261 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-02-23 | 2022-02-22+ | CRL | Barbo William D | CCO, Corp. Executive VP | F - Tax | $291.50 | -602 | 4,084 | -13% | -$175.5K |
| 2022-02-23 | 2022-02-08 | CRL | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | -6,178 | 4,371 | -59% | $0 | |
| I | 2022-02-23 | 2022-02-08 | CRL | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | +6,178 | 18.1K | +52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-23 | F | D | 315 | $289.58 | 3,769 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-08 | G | D | 6,178 | $0.00 | 4,371 | D By Trust | — | — | |
| 3 | Common | Common Stock | 2022-02-08 | G | A | 6,178 | $0.00 | 18,090 | I | — | — | |
| 4 | Common | Common Stock | 2022-02-22 | F | D | 287 | $293.61 | 4,084 | D | — | — |